Physician profile
Arnold Mclendon
NPI 1871016618
$2,292.75
in general payments reported to CMS, 2019-2025
18 companies · $270 in 2025
The $270 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $328 · 2022: $249 · 2023: $881 · 2024: $565 · 2025: $270.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,716.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,715.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $704.38 | 2021-2025 | Rybelsus, Ozempic, Wegovy |
| Abbvie INC. | $392.80 | 2021-2024 | |
| Abbott Laboratories | $227.55 | 2023 | Freestyle Libre 3, Freestyle Libre 2 |
| Lilly USA, LLC | $180.05 | 2021-2025 | Zepbound, Mounjaro |
| Astrazeneca Pharmaceuticals LP | $170.59 | 2021-2025 | Breztri, Airsupra |
| Otsuka America Pharmaceutical, INC. | $105.70 | 2023-2024 | Rexulti |
| Urovant Sciences INC | $102.60 | 2022 | |
| Shield Therapeutics INC | $82.65 | 2023-2024 | Accrufer |
| Sunovion Pharmaceuticals INC. | $70.17 | 2022 | |
| Exact Sciences Corporation | $64.33 | 2023-2025 | Cologuard Collection Kit |
| Eisai INC. | $34.93 | 2024 | |
| Dexcom, INC. | $34.33 | 2024 | Dexcom G6 Transmitter |
| Boston Scientific Corporation | $29.10 | 2025 | Wavewriter Alpha Prime 16 |
| Amgen INC. | $27.01 | 2021-2023 | Otezla, Repatha |
| Pfizer INC. | $19.58 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.36 | 2023 | Jardiance, Stiolto Respimat, Spiriva Respimat |
| Axsome Therapeutics, INC. | $15.40 | 2024 | Sunosi |
| Merck Sharp & Dohme LLC | $13.22 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arnold Mclendon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.